In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435

TMC435 is a small-molecule inhibitor of the NS3/4A serine protease of hepatitis C virus (HCV) currently in phase 2 development. The in vitro resistance profile of TMC435 was characterized by selection experiments with HCV genotype 1 replicon cells and the genotype 2a JFH-1 system. In 80% (86/109) of...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Lenz, Oliver, Verbinnen, Thierry, Lin, Tse-I, Vijgen, Leen, Cummings, Maxwell D., Lindberg, Jimmy, Berke, Jan Martin, Dehertogh, Pascale, Fransen, Els, Scholliers, Annick, Vermeiren, Katrien, Ivens, Tania, Raboisson, Pierre, Edlund, Michael, Storm, Susan, Vrang, Lotta, de Kock, Herman, Fanning, Gregory C., Simmen, Kenneth A.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology (ASM) 2010
Предметы:
Antiviral Agents
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2863659/
https://ncbi.nlm.nih.gov/pubmed/20176898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01452-09
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы